HSBC Holdings’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

HSBC Holdings’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-384,777	Closed	-$15.2M	–	2930
2023 Q2	$15.2M	Buy	384,777 +297,414	+340%	+$10.5M	0.02%	695
2023 Q1	$2.13M	Buy	+87,363	New	+$1.91M	﹤0.01%	1483

HSBC Holdings's ISEE Position: Q3 2023 in Review

HSBC Holdings sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 384,777 shares — an estimated $15.2M sold.

HSBC Holdings first reported a position in ISEE in Q1 2023 and held it in 2 quarters. The position peaked at $15.2M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

HSBC Holdings reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
HSBC Holdings sold 384,777 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $15.2M.
HSBC Holdings first reported a position in IVERIC bio, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
HSBC Holdings's IVERIC bio, Inc. Common Stock position peaked at $15.2M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.